Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
批准号:
10601330
负责人:
Rachel B. Issaka
金额:
$8.51万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2024-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Rachel Issaka, MD, MAS’ long-term career goal is to become an independent researcher and leader in
developing, implementing, and evaluating interventions to reduce colorectal cancer (CRC) mortality in medically
underserved populations. She has identified improving follow-up of abnormal fecal immunochemical test (FIT)
results as a critical issue to address to achieve this goal. This proposal describes a 5-year comprehensive
program of training and mentored research for an academic career in health outcomes research. The research
agenda is in line with one of NCI’s five scientific goals: to improve cancer prevention and control. In this goal,
advancing health care equity in medically underserved populations is an area of special focus. While Dr. Issaka
has a strong background in clinical gastroenterology and safety-net systems-level research, this K08 will provide
key training in advanced multilevel statistical modeling, qualitative research methods, mixed methods research,
and intervention development. FIT is promoted over colonoscopy for CRC screening in federally qualified health
centers (FQHCs) and safety-net health systems due to patient preference and limited colonoscopy resources.
For FIT-based screening to effectively reduce CRC-mortality, abnormal results must be followed by a diagnostic
colonoscopy. However, FQHCs and safety-net health systems do not consistently track follow-up of abnormal
FIT results and failure to complete a diagnostic colonoscopy increases CRC-mortality by up to 3-fold. Research
suggests approximately 50% of safety-net patients with an abnormal FIT do not complete a diagnostic
colonoscopy within 1 year of their result. This highlights the importance of identifying and describing the barriers
to diagnostic colonoscopy completion after abnormal FIT results in order to develop effective interventions. The
study’s specific aims are: (1) using mixed methods, identify the potentially modifiable patient, provider, and clinic-
level barriers to diagnostic colonoscopy in patients with abnormal FIT results in a large safety-net health system;
and (2) based upon intervention targets identified in Aim 1, develop a pilot intervention to improve diagnostic
colonoscopy completion in a safety-net population with abnormal FIT results. Dr. Issaka’s mentorship team
including world-renowned gastroenterologists, health services researchers, qualitative and mixed methods
experts and implementation scientists will provide experiential guidance to complement her didactic training.
These factors in addition to the supportive research environments at the Fred Hutchinson Cancer Research
Center and the University of Washington, will enable her to achieve the proposed project aims. Upon completion
of the proposed research and training, Dr. Issaka will submit a competitive R-level grant application to test the
pilot intervention in a randomized trial and will possess the skills and experience to make sustained and impactful
contributions to reduce CRC-mortality through evidence-based interventions that improve follow-up of abnormal
FIT results.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
-
批准号:9806781
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2019
-
负责人:Rachel B. Issaka
-
依托单位:
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
-
批准号:10472516
-
项目类别:
-
资助金额:$22.57万
-
财政年份:2019
-
负责人:Rachel B. Issaka
-
依托单位:
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
-
批准号:10684912
-
项目类别:
-
资助金额:$22.36万
-
财政年份:2019
-
负责人:Rachel B. Issaka
-
依托单位:
国内基金
海外基金
登录
查看更多内容
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
环境抗雄激素干预AR/TGFB1I1致尿道下裂血管内皮细胞发育异常的机制及其“预警信号”在早期诊断中的价值
-
批准号:82371605
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:蒋君涛
-
依托单位:
弓状核介导慢性疼痛引起动机下降的神经环路机制及rTMS干预研究
-
批准号:82371536
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张松
-
依托单位:
放疗通过激活GSDMD诱发细胞焦亡促进肿瘤再增殖的机制研究及干预策略探讨
-
批准号:82373299
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:程进
-
依托单位:
生殖腺调控衰老的机理研究
-
批准号:32070731
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:沈义栋
-
依托单位:
血液蛋白参与肝细胞衰老可逆性调控机制的研究
-
批准号:32070732
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:王敏君
-
依托单位:
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
-
批准号:81973152
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2019
-
负责人:胡东生
-
依托单位:
亚纳米单分子定位技术研究化学修饰对蛋白-膜相互作用的干预
-
批准号:91753104
-
项目类别:重大研究计划
-
资助金额:70.0万元
-
批准年份:2017
-
负责人:李明
-
依托单位:
我国家庭环境下的食品安全风险评价及综合干预研究
-
批准号:71103074
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2011
-
负责人:白丽
-
依托单位: